News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Life Science Pharmaceuticals, Inc. Enters Into Agreement With Abbott GmbH to Develop Antibody 806


11/17/2008 10:59:50 AM

GREENWICH, Conn.--(BUSINESS WIRE)--Life Science Pharmaceuticals, Inc. announced today that it has entered into a license agreement with Abbott to develop Antibody 806, which may prove to be an important tool in the fight against cancer.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES